236 related articles for article (PubMed ID: 32562556)
21. Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis.
Zhang XK; Wang YY; Chen JW; Qin T
Int J Clin Exp Pathol; 2015; 8(5):5549-55. PubMed ID: 26191263
[TBL] [Abstract][Full Text] [Related]
22. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.
Kaymaz E; Ozer E; Unverdi H; Hucumenoglu S
Indian J Pathol Microbiol; 2017; 60(4):510-514. PubMed ID: 29323063
[TBL] [Abstract][Full Text] [Related]
24. Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.
Lee H; Jun SY; Lee YS; Lee HJ; Lee WS; Park CS
Virchows Arch; 2014 Feb; 464(2):213-20. PubMed ID: 24306957
[TBL] [Abstract][Full Text] [Related]
25. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
26. Histologic grading of noninvasive papillary urothelial neoplasms.
MacLennan GT; Kirkali Z; Cheng L
Eur Urol; 2007 Apr; 51(4):889-97; discussion 897-8. PubMed ID: 17095142
[TBL] [Abstract][Full Text] [Related]
27. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
28. Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms.
Izumiyama-Shimomura N; Nakamura K; Aida J; Ishikawa N; Kuroiwa M; Hiraishi N; Fujiwara M; Ishikawa Y; Inoshita N; Yonese J; Matsuura M; Poon SS; Arai T; Takubo K
Urol Oncol; 2014 Feb; 32(2):135-45. PubMed ID: 23510865
[TBL] [Abstract][Full Text] [Related]
29. Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?
Garbar C; Mascaux C
Anal Quant Cytol Histol; 2011 Oct; 33(5):277-82. PubMed ID: 22611755
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature.
Jaworski D; Szylberg Ł; Gzil A; Stawinski P; Kasperska A; Marszałek A
Ann Diagn Pathol; 2019 Jun; 40():182-188. PubMed ID: 29395466
[TBL] [Abstract][Full Text] [Related]
31. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
Helpap B; Köllermann J
Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
[TBL] [Abstract][Full Text] [Related]
33. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
Barbisan F; Santinelli A; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; van der Kwast T; Montironi R
Cancer; 2008 Feb; 112(3):636-44. PubMed ID: 18072261
[TBL] [Abstract][Full Text] [Related]
34. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).
Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
J Cancer; 2017; 8(15):2885-2891. PubMed ID: 28928878
[No Abstract] [Full Text] [Related]
35. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Hentschel AE; van Rhijn BWG; Bründl J; Compérat EM; Plass K; Rodríguez O; Henríquez JDS; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Scavarda-Lamberti A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Cohen D; Lunelli L; Cussenot O; Sheikh SE; Volanis D; Coté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Babjuk M; van der Kwast TH; Sylvester RJ
Urol Oncol; 2020 May; 38(5):440-448. PubMed ID: 31704141
[TBL] [Abstract][Full Text] [Related]
36. Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections.
Castellini P; Montironi MA; Zizzi A; Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; Paone N; Montironi R
Hum Pathol; 2014 Apr; 45(4):745-52. PubMed ID: 24565208
[TBL] [Abstract][Full Text] [Related]
37. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old.
Compérat E; Larré S; Roupret M; Neuzillet Y; Pignot G; Quintens H; Houéde N; Roy C; Durand X; Varinot J; Vordos D; Rouanne M; Bakhri MA; Bertrand P; Jeglinschi SC; Cussenot O; Soulié M; Pfister C
Virchows Arch; 2015 May; 466(5):589-94. PubMed ID: 25697540
[TBL] [Abstract][Full Text] [Related]
39. Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
Zaleski M; Gogoj A; Walter V; Raman JD; Kaag M; Merrill SB; Drabick J; Joshi M; Holder S; DeGraff DJ; Warrick JI
Hum Pathol; 2019 Feb; 84():275-282. PubMed ID: 30359638
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
